NUP62CL
Basic information
Region (hg38): X:107123426-107206433
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NUP62CL gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 10 | 11 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 10 | 2 | 0 |
Variants in NUP62CL
This is a list of pathogenic ClinVar variants found in the NUP62CL region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-107153217-C-G | not specified | Uncertain significance (Jan 18, 2022) | ||
X-107153227-G-A | not specified | Uncertain significance (Jul 19, 2022) | ||
X-107153229-G-A | not specified | Likely benign (May 01, 2022) | ||
X-107153499-C-T | not specified | Uncertain significance (Nov 27, 2023) | ||
X-107154124-T-C | not specified | Uncertain significance (Jul 06, 2021) | ||
X-107154191-A-G | not specified | Uncertain significance (Oct 27, 2022) | ||
X-107154209-C-T | not specified | Uncertain significance (Apr 06, 2024) | ||
X-107154222-T-C | Likely benign (Aug 01, 2022) | |||
X-107167685-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
X-107167739-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
X-107167740-T-C | not specified | Uncertain significance (Sep 23, 2023) | ||
X-107167773-T-C | not specified | Uncertain significance (Mar 21, 2022) | ||
X-107175121-G-T | not specified | Uncertain significance (Aug 21, 2023) | ||
X-107175128-A-G | not specified | Uncertain significance (Sep 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NUP62CL | protein_coding | protein_coding | ENST00000372466 | 6 | 83014 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00131 | 0.666 | 125638 | 4 | 1 | 125643 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.268 | 54 | 59.8 | 0.902 | 0.00000409 | 1175 |
Missense in Polyphen | 8 | 9.6879 | 0.82577 | 244 | ||
Synonymous | 0.783 | 19 | 23.9 | 0.796 | 0.00000172 | 354 |
Loss of Function | 0.679 | 5 | 6.93 | 0.721 | 4.37e-7 | 137 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000727 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000123 | 0.00000880 |
Middle Eastern | 0.0000727 | 0.0000544 |
South Asian | 0.000185 | 0.0000982 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Pathway
- Glycolysis and Gluconeogenesis;Leukotriene metabolism;Squalene and cholesterol biosynthesis;Purine metabolism;Vitamin B3 (nicotinate and nicotinamide) metabolism;Vitamin B5 - CoA biosynthesis from pantothenate;Pyrimidine metabolism;Glycosphingolipid metabolism;Phosphatidylinositol phosphate metabolism;Lysine metabolism;Methionine and cysteine metabolism;Selenoamino acid metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Aminosugars metabolism;Pentose phosphate pathway;De novo fatty acid biosynthesis;Glycerophospholipid metabolism;Prostaglandin formation from dihomo gama-linoleic acid;Putative anti-Inflammatory metabolites formation from EPA;Vitamin D3 (cholecalciferol) metabolism;Vitamin E metabolism;Glycine, serine, alanine and threonine metabolism;Arachidonic acid metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0646
Intolerance Scores
- loftool
- 0.687
- rvis_EVS
- 0.81
- rvis_percentile_EVS
- 87.82
Haploinsufficiency Scores
- pHI
- 0.0621
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.412
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.273
Mouse Genome Informatics
- Gene name
- Nup62cl
- Phenotype
Gene ontology
- Biological process
- nucleocytoplasmic transport;protein transport
- Cellular component
- nuclear pore
- Molecular function
- protein binding;structural constituent of nuclear pore